This is an exciting time for the advancement in therapies designed specifically for Sjögren’s patients! Currently there are twelve companies in clinical trials with sixteen therapies that we hope will prove successful for Sjögren’s patients. However, patient participation is critical to ensure effective drugs can advance through the clinical trial process, and eventually come to market. COVID-19 did slow-down the clinical trial recruitment process, but companies are now re-engaging with patients as the majority of patients have been fully vaccinated.
Each clinical trial has specific criteria for participating. So, when you call a site, they will ask you specific questions to see if you are eligible. Please know that calling a site is showing an interest in the trial (and not necessarily a commitment). So do call and demonstrate your interest! It is also important to demonstrate that there is demand for new therapeutics even if you choose not to participate after learning more.
If you are interested in learning more about clinical trials, please take a look at the information on our Clinical Trials page. Then click the Clinical Trial Locations to see if there is a location near you. And then give them a call! Sites are taking special precautions regarding COVID, and you can ask each site how they keep patients safe. And remember, calling to inquire about the program is the first step to learning if the trial is the right opportunity for you!